Vulnerable plaque overview

129
#1 killer of human beings in the 21 st century?

Transcript of Vulnerable plaque overview

Page 1: Vulnerable plaque overview

#1 killer of human

beings in the 21st century?

Page 2: Vulnerable plaque overview

Fatal Heart Attack!

Page 3: Vulnerable plaque overview

What causes heart attack?

Page 4: Vulnerable plaque overview

Vulnerable Plaque

The short answer is:

Page 5: Vulnerable plaque overview

What is vulnerable plaque?

Page 6: Vulnerable plaque overview

Dangerous forms of atherosclerotic plaques

that can rupture or induce thrombosis and

lead to critical disruption of blood flow.

The short answer is:

Page 7: Vulnerable plaque overview

Everybody has atherosclerosis, the question is who has vulnerable plaque

Sudden Cardiac DeathAcute MI

Page 8: Vulnerable plaque overview

What Do We Know About Vulnerable Plaque?

Morteza Naghavi, MD

Center for Vulnerable Plaque ResearchUniversity of Texas at Houston

Texas Heart InstituteOctober 2001

Mohammad Madjid, MD Silvio Litovsky, MD Alireza Zarrabi, MDMaziar Azadpour, MD Parsa Mirhaji, MD Cornelius Nwora, MD

Ward Casscells, MD James Willerson, MD

Page 9: Vulnerable plaque overview

Salute to Pioneers

Page 10: Vulnerable plaque overview

Carl von Rokitansky (1804-1878)

Rokitansky gave early detailed descriptions of arterial disease. He

is alleged to have performed 30,000

autopsies.

Rokitansky in 1841 championed the Thrombogenic Theory. He proposed that the deposits observed in the inner layer of the arterial wall

derived primarily from fibrin and other blood elements rather than being the result of a purulent process. Subsequently, the atheroma resulted from the

degeneration of the fibrin and other blood proteins as a result of a preexisting crasis of the blood, and finally these deposits were modified toward a pulpy

mass containing cholesterol crystals and fatty globules. This theory came under attack by Virchow

Page 11: Vulnerable plaque overview

First studies on inflammation of vessels, particularly phlebitis, Started at a time when Cruveilhier2had just stated: La phlebite domine toute la pathologie.3 First a great number of preparatory studies on fibrin, leukocytes, meta-morphosis of blood, published separately. …

Rudolf Virchow 1821-1902

The Father of Cellular Pathology

Virchow appreciates prior works.

Virchow presented his inflammatory theory. He utilized the name of "endarteritis deformans." By this he meant that the atheroma was a product of an inflammatory process within the intima with the fibrous thickening evolved as a consequence of a reactive fibrosis induced by proliferating connective tissue cells within the intima.

Page 12: Vulnerable plaque overview

Olcott 1931 “plaque rupture”

Leary 1934 “rupture of atheromatous abscess”

Wartman 1938 “rupture-induced occlusion”

Horn 1940 “plaque fissure”

Helpern 1957 “plaque erosion”

Crawford 1961 “plaque thrombosis”

Gore 1963 “plaque ulceration”

Friedman 1964 “macrophage accumulation”

Byers 1964 “thrombogenic gruel”

Chapman 1966 “plaque rupture”

Plaque Fissure in Human Coronary Thrombosis (Abstract) Fed. Proc. 1964, 23, 443 Paris Constantinidis

“The destruction of the hyalinized wall separating lumen from the atheroma was almost always observed to be preceded by or associated with its invasion by lipid containing macrophages.”

Friedman and van den Bovenkamp 1965

Unheralded Pioneers

Page 13: Vulnerable plaque overview

N Engl J Med 1999

“Atherosclerosis; an inflammatory disease”

Ross R.

Russell Ross

Atherosclerosis; arterial “Response to Injury”

N Engl J Med 1976 Aug 12;295(7):369-77 The pathogenesis of atherosclerosis (first of two parts).Ross R, Glomset JA.

Page 14: Vulnerable plaque overview

James T. Willerson 1981N Engl J Med 1981 Mar 19;304(12):685-91

Plaque Thrombosis

Page 15: Vulnerable plaque overview

Erling Falk Michael Davies

Autopsy Series

Thin Fibrous Cap + Large Lipid Core + Dense Macrophage

A culprit ruptured plaque

1981-1990

Page 16: Vulnerable plaque overview
Page 17: Vulnerable plaque overview

Seymour GlagovCompensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 1987 May

28;316(22):1371-5

<50% stenosis

Luminal area is not endangered until more than 40% of IEL is destructed and occupied by plaque

Coronary artery disease is a disease of arterial wall disease not lumen.

Page 18: Vulnerable plaque overview

Angiographic progression of coronary artery disease and the development of myocardial infarction.Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V.

Department of Medicine, New York Cardiac Center, Mount Sinai Medical Center, New York 10029.

Simultaneously, Little et al, Haft et al reported that majority of culprit lesions are found on previously non-critical stenosis plaques.

Conclusion: “Myocardial infarction frequently develops from non-severe lesions.”

J Am Coll Cardiol 1988 Jul;12(1):56-62

Ambrose, Fuster, and colleagues

Angiographically Invisible Plaques

Page 19: Vulnerable plaque overview

Falk E., Shak P.K., Fuster V. Circulation 1995

Non-stenotic (<75%) plaques cause about 80% of deadly MI

Page 20: Vulnerable plaque overview

Macrophage- driven MMPs soften plaque cap and prompt it to rupture

P.K. Shah

Peter LibbyAtherosclerosis and its thrombotic complication is governed by immune

cells.

Goran Hansson…

Allard van der Wal

Page 21: Vulnerable plaque overview

Muller JE, Abela GS, Nesto RW, Tofler GH.

Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier.

J Am Coll Cardiol. 1994 Mar 1;23(3):809-13

James E. Muller 1994

Muller coined the term of “Vulnerable” Plaque

Muller likened Vulnerable Plaques to American nuclear missiles stored underground in Nevada desert where they could be vulnerable to Russians’ long-range missile attack!

Page 22: Vulnerable plaque overview

•Eroded Plaque

Rupture-prone plaques are not the only type of vulnerable plaque

•Calcium Nodulevan der Wal - Netherlands

Renu Virmani -USA

Thiene - Italy

Kolodgie F., Burk A.P., Farb A., and Virmani R.

Page 23: Vulnerable plaque overview

“Who is Who” on

www.VP.org

The field of vulnerable plaque is best owed to many known and unknown

scientists who have worked hard to shed light on our way to prevent and

eradicate heart attacks in the future. To see a more complete list please visit:

Page 24: Vulnerable plaque overview

Natural History ofVulnerable Plaques

Illustrated:

Page 25: Vulnerable plaque overview

~65%

Percent of stenosis

Frequency of plaques

“Risk” per each plaque

Culprit Risk per each type of Vulnerable Plaque

(Log)

Culprit lesions found in autopsy series of acute MI

Different Types of Plaque Vulnerable to Thrombosis

All

Male

Female

~10% <5% ~20%

50%

Angiography

~70% <5% ~20%

~55% ~20%

<5%

<5% ~20%

Rupture Prone Eroded Calcified NoduleHemorrhage

Positive Remodeling

Fissured /Healed

Natural History of Vulnerable Atherosclerotic Plaques

Page 26: Vulnerable plaque overview

Ruptured Plaques (~70%)1. Stenotic (~20%)2. Non-stenotic (~50%)

Non-ruptured Plaques (~ 30%)1.Erosion (~20%)2.Calcified Nodule (~5%)3.Others / Unknown (~5%)

Plaque Pathology Responsible for Coronary Thrombotic Death

In summary:

Page 27: Vulnerable plaque overview

Culprit Plaque; a retrospective terminology 

Vulnerable Plaque; a prospective terminology

Vulnerable Plaque = Future Culprit Plaque

Clarification of Terminologies

Page 28: Vulnerable plaque overview

Rupture-Prone Plaque

Vulnerable Plaque Naghavi et al, Cur Ath Rep 2001

Macrophage

Necrotic Lipid Core

Thin Fibrous Cap

Page 29: Vulnerable plaque overview

Eroded Plaque

Vulnerable Plaque Naghavi et al, Cur Ath Rep 2001

Page 30: Vulnerable plaque overview

Fissured / Healed Plaque

Vulnerable Plaque Naghavi et al, Cur Ath Rep 2001

Page 31: Vulnerable plaque overview

Plaque with a Subluminal Calcified Nodule

Vulnerable Plaque Naghavi et al, Cur Ath Rep 2001

Page 32: Vulnerable plaque overview

Intra-Plaque Hemorrhage with Intact Cap

Vulnerable Plaque Naghavi et al, Cur Ath Rep 2001

Page 33: Vulnerable plaque overview

Critically Stenotic but Asymptomatic Plaque

Naghavi et al, Cur Ath Rep 2001Vulnerable Plaque

Page 34: Vulnerable plaque overview
Page 35: Vulnerable plaque overview
Page 36: Vulnerable plaque overview
Page 37: Vulnerable plaque overview
Page 38: Vulnerable plaque overview
Page 39: Vulnerable plaque overview
Page 40: Vulnerable plaque overview
Page 41: Vulnerable plaque overview
Page 42: Vulnerable plaque overview
Page 43: Vulnerable plaque overview
Page 44: Vulnerable plaque overview
Page 45: Vulnerable plaque overview
Page 46: Vulnerable plaque overview
Page 47: Vulnerable plaque overview
Page 48: Vulnerable plaque overview
Page 49: Vulnerable plaque overview
Page 50: Vulnerable plaque overview
Page 51: Vulnerable plaque overview
Page 52: Vulnerable plaque overview
Page 53: Vulnerable plaque overview
Page 54: Vulnerable plaque overview
Page 55: Vulnerable plaque overview
Page 56: Vulnerable plaque overview
Page 57: Vulnerable plaque overview
Page 58: Vulnerable plaque overview
Page 59: Vulnerable plaque overview
Page 60: Vulnerable plaque overview
Page 61: Vulnerable plaque overview
Page 62: Vulnerable plaque overview
Page 63: Vulnerable plaque overview
Page 64: Vulnerable plaque overview
Page 65: Vulnerable plaque overview
Page 66: Vulnerable plaque overview
Page 67: Vulnerable plaque overview
Page 68: Vulnerable plaque overview
Page 69: Vulnerable plaque overview
Page 70: Vulnerable plaque overview
Page 71: Vulnerable plaque overview
Page 72: Vulnerable plaque overview
Page 73: Vulnerable plaque overview
Page 74: Vulnerable plaque overview
Page 75: Vulnerable plaque overview
Page 76: Vulnerable plaque overview
Page 77: Vulnerable plaque overview
Page 78: Vulnerable plaque overview
Page 79: Vulnerable plaque overview
Page 80: Vulnerable plaque overview
Page 81: Vulnerable plaque overview
Page 82: Vulnerable plaque overview
Page 83: Vulnerable plaque overview
Page 84: Vulnerable plaque overview
Page 85: Vulnerable plaque overview
Page 86: Vulnerable plaque overview
Page 87: Vulnerable plaque overview
Page 88: Vulnerable plaque overview
Page 89: Vulnerable plaque overview
Page 90: Vulnerable plaque overview
Page 91: Vulnerable plaque overview
Page 92: Vulnerable plaque overview
Page 93: Vulnerable plaque overview
Page 94: Vulnerable plaque overview
Page 95: Vulnerable plaque overview
Page 96: Vulnerable plaque overview
Page 97: Vulnerable plaque overview
Page 98: Vulnerable plaque overview
Page 99: Vulnerable plaque overview
Page 100: Vulnerable plaque overview
Page 101: Vulnerable plaque overview
Page 102: Vulnerable plaque overview
Page 103: Vulnerable plaque overview
Page 104: Vulnerable plaque overview
Page 105: Vulnerable plaque overview
Page 106: Vulnerable plaque overview
Page 107: Vulnerable plaque overview
Page 108: Vulnerable plaque overview
Page 109: Vulnerable plaque overview
Page 110: Vulnerable plaque overview
Page 111: Vulnerable plaque overview
Page 112: Vulnerable plaque overview
Page 113: Vulnerable plaque overview
Page 114: Vulnerable plaque overview
Page 115: Vulnerable plaque overview
Page 116: Vulnerable plaque overview
Page 117: Vulnerable plaque overview
Page 118: Vulnerable plaque overview
Page 119: Vulnerable plaque overview
Page 120: Vulnerable plaque overview
Page 121: Vulnerable plaque overview
Page 122: Vulnerable plaque overview
Page 123: Vulnerable plaque overview
Page 124: Vulnerable plaque overview
Page 125: Vulnerable plaque overview
Page 126: Vulnerable plaque overview
Page 127: Vulnerable plaque overview
Page 128: Vulnerable plaque overview
Page 129: Vulnerable plaque overview